Prolonged weakness in North America and BFSI
North America revenue declined 3% YoY and BFSI degrew 3% YoY. Management could not provide a timeline for recovery, citing macro uncertainties.
TCS / Q3-FY24 / risks
Keep the risk register visible.
TCS · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Disconnect between TCV and revenue growth
Analyst noted that despite strong deal wins, revenue growth has been muted, partly due to reprioritization of older programs. Management confirmed this trend.
GenAI revenue impact uncertain
GenAI is still in early stages with only four production deployments. Management could not provide a timeline for meaningful revenue contribution.
Employee headcount decline may continue
Headcount declined by 5,600 in Q3. CHRO said further decline would not be surprising, which could signal lower utilization or demand.